Table of Contents

• 1.1 List of Tables 7
• 1.2 List of Figures 8

2 Introduction 9

• 2.1 Clinical Chemistry Analyzers Overview 9

3 Products under Development 10

• 3.1 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 10
• 3.2 Clinical Chemistry Analyzers - Pipeline Products by Segment 11
• 3.3 Clinical Chemistry Analyzers - Pipeline Products by Territory 12
• 3.4 Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 13
• 3.5 Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 14
• 3.6 Clinical Chemistry Analyzers - Ongoing Clinical Trials 15

4 Clinical Chemistry Analyzers - Pipeline Products under Development by Companies 16

• 4.1 Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development 16
• 4.2 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 17

5 Clinical Chemistry Analyzers Companies and Product Overview 18

• 5.1 Abreos Biosciences Inc Company Overview 18
  • 5.1.1 Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.2 Advanced Liquid Logic Inc Company Overview 20
  • 5.2.1 Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.3 All Medicus Co Ltd Company Overview 21
  • 5.3.1 All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 Arogyam Medisoft Solution Pvt Ltd Company Overview 22
  • 5.4.1 Arogyam Medisoft Solution Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.5 AutoGenomics Inc Company Overview 23
  • 5.5.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.6 Aviv Biomedical, Inc. Company Overview 25
  • 5.6.1 Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.7 Curetis NV Company Overview 28
  • 5.7.1 Curetis NV Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.8 Daxor Corp Company Overview 29
  • 5.8.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.9 DiaSys Diagnostic Systems GmbH Company Overview 30
  • 5.9.1 DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.10 EKF Diagnostics Holdings Plc Company Overview 31
  • 5.10.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.11 Emergent Detection Inc (Inactive) Company Overview 33
  • 5.11.1 Emergent Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.12 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 34
  • 5.12.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.13 Hitachi Chemical Co Ltd Company Overview 35
  • 5.13.1 Hitachi Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.14 Invivomon Inc (Inactive) Company Overview 36
  • 5.14.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.15 Luminex Corp Company Overview 37
  • 5.15.1 Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.16 MyCartis NV Company Overview 38
  • 5.16.1 MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.17 NanoIVD Inc Company Overview 39
  • 5.17.1 NanoIVD Inc Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.18 Ortho-Clinical Diagnostics Inc Company Overview 40
  • 5.18.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.19 Smiths Diagnostics Medical Company Overview 41
  • 5.19.1 Smiths Diagnostics Medical Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.20 The Hong Kong University of Science and Technology Company Overview 42
  • 5.20.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.21 Theranos Inc Company Overview 43
  • 5.21.1 Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.22 Thermal Gradient Inc Company Overview 44
  • 5.22.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.23 Thermo Fisher Scientific Inc Company Overview 45
  • 5.23.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 45

6 Clinical Chemistry Analyzers- Recent Developments 46

• 6.1 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 46
• 6.2 Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA 47
• 6.3 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 48
• 6.4 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 49
• 6.5 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019 50
• 6.6 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 51
• 6.7 Oct 29, 2019: Illumina celebrates grand opening of its solutions center in the University of Maryland BioPark 54
• 6.8 Oct 29, 2019: ELITechGroup announces direct sales and customer support in Canada 55
• 6.9 Oct 29, 2019: Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million 55
• 6.10 Oct 28, 2019: Siemens announces new management team for Siemens Energy 56

7 Appendix 216

• 7.1 Methodology 216
• 7.2 About GlobalData 219
• 7.3 Contact Us 219

Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Clinical Chemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Clinical Chemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Clinical Chemistry Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Clinical Chemistry Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Clinical Chemistry Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date